Senate bill · 89R

SB 556

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

Did not pass

Progress

56 days from first to latest action, across 4 recorded actions.

Filed
Dec 9
Referred to committee
Feb 3
Heard in committee
Stopped here
Reported from committee
Passed first chamber
Passed second chamber
Sent to governor
Became law

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

Referred to Education K-16 Education
Feb 3, 2025 · Senate
Read first time
Feb 3, 2025 · Senate
Filed
Dec 9, 2024 · Senate
Received by the Secretary of the Senate
Dec 9, 2024 · Senate

Authors

Nathan JohnsonD

In committee

Education
Senate
Referred Feb 3, 2025 · never reported

Topics

Alcoholism & Drug Abuse Crimes: Drugs Education: Higher: General Education: Higher: Institutions & Programs Health Care Providers Health: Other Diseases & Medical Conditions

Bill text

IntroducedHTML PDF

Bills on similar topics

Other legislation this session sharing the most index topics.

Bill	Author	Progress	Status	Last action
HB 1103Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.	Sheryl ColeD	Referred to committee	Did not pass	Mar 7, 2025Referred to Higher Education
SB 2308Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.	Tan ParkerR	Became law	Became law	Jun 11, 2025Effective immediately
HB 5465Relating to procedures regarding certain persons who are or may be persons with a mental illness or intellectual or developmental disability.	Joe MoodyD	Reported from committee	Did not pass	May 13, 2025Placed on General State Calendar
HB 253Relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of a substance listed in Penalty Group 1-B.	James TalaricoD	Referred to committee	Did not pass	Feb 27, 2025Referred to Public Health
HB 1504Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and cannabis testing facilities; authorizing fees.	Ron ReynoldsD	Referred to committee	Did not pass	Mar 12, 2025Referred to Public Health
HJR 70Proposing a constitutional amendment to direct the legislature to authorize and regulate the possession, cultivation, and sale of cannabis for medical use.	Ron ReynoldsD	Referred to committee	Did not pass	Mar 4, 2025Referred to Public Health